KPC Pharmaceuticals, Inc.: Notice of Implementation of Annual Equity Distribution of KPC Pharmaceuticals, Inc. in 2023
Notice of Implementation of Annual Equity Distribution of KPC Pharmaceuticals, Inc. in 2023
Investor Relations Activity Record Form (2024-005) of KPC Pharmaceuticals, Inc.
Legal opinion by Deheng (Kunming) Law Firm regarding the Fourth Interim Shareholders' Meeting of KPC Pharmaceuticals, Inc. in 2024.
KPC Pharmaceuticals, Inc. announcement regarding repurchase and cancellation of restricted stocks and notifying creditors.
Announcement of the Fourth Extraordinary Shareholders' Meeting Resolution of KPC Pharmaceuticals, Inc. in 2024.
Announcement of progress on external guarantee by KPC Pharmaceuticals, Inc.
Announcement of the appointment of senior management personnel at Kpc Pharmaceuticals, Inc.
Legal opinion of Deheng Law Firm (Kunming) regarding the 2023 annual shareholder meeting of KPC Pharmaceuticals, Inc.
Announcement of the resolution of the annual shareholder meeting of KPC Pharmaceuticals, Inc. in 2023.
2024 KPC Pharmaceuticals, Inc. Fourth Interim Shareholders' Meeting Conference Materials.
KPC Pharmaceuticals, Inc. investor relations activity record form (2024-004)
KPC Pharmaceuticals, Inc. 2023 Annual Shareholders' Meeting Materials.
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. intends to transfer a 51% stake in Kunming China Resources Shenghuo Pharmaceutical Co., Ltd. to KPC Pharmaceuticals, Inc. Asset evaluation report of the project.
Notice of the Fourth Extraordinary Shareholders' Meeting of KPC Pharmaceuticals, Inc. in 2024.
Announcement of the Resolution of the 28th Board of Directors Meeting of KPC Pharmaceuticals, Inc.
KPC Pharmaceuticals, Inc. Donations Management System for External Use (Revised in June 2024)
Announcement of the resolution of the 24th Supervisory Board Meeting of KPC Pharmaceuticals, Inc.
Announcement of kpc pharmaceuticals, inc. Acquisition of 51% equity of Kunming CR Sanjiu Pharmaceutical Co., Ltd. and related transactions.
Audited financial statements for the fiscal year ending December 31, 2023 of Kunming Huarun Shenghuo Pharmaceutical Co., Ltd.
No Data